|4Mar 29, 6:12 PM ET

Auster Martin 4

4 · Ventyx Biosciences, Inc. · Filed Mar 29, 2024

Insider Transaction Report

Form 4
Period: 2024-03-28
Auster Martin
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2024-03-28+4,53125,708 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-03-284,53113,594 total
    Common Stock (4,531 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of Ventyx Biosciences, Inc. common stock.
  • [F2]Twenty-five percent (25%) of the restricted stock units subject to the RSU Award shall vest on the one (1) year anniversary of the RSU Vesting Commencement Date (as defined below), and twenty-five percent (25%) of the total restricted stock units subject to the RSU Award shall vest each year thereafter on each annual anniversary of the RSU Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), subject to the reporting person continuing to be a Service Provider (as defined in the Plan) through each such date. The RSU Vesting Commencement Date shall mean March 28, 2023.

Documents

1 file
  • 4
    form4-03292024_100315.xmlPrimary